Basilea Pharmaceutica AG (SWX: BSLN)

Basilea Pharmaceutica AG Revenue

Basilea Pharmaceutica AG had revenue of 31.84M CHF in the half year ending June 30, 2024, with 205.43% growth. This brings the company's revenue in the last twelve months to 52.54M, up 157.23% year-over-year. In the year 2023, Basilea Pharmaceutica AG had annual revenue of 33.56M with 86.61% growth.

• Revenue (ttm): 52.54M
• Revenue Growth: +157.23%
• P/S Ratio: 3.68
• Revenue / Employee: 955.27K
• Employees: 147
• Market Cap: 552.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	33.56M	15.58M	86.61%
Dec 31, 2022	17.99M	4.17M	30.19%
Dec 31, 2021	13.82M	9.78M	242.04%
Dec 31, 2020	4.04M	1.48M	57.71%
Dec 31, 2019	2.56M	1.85M	258.18%